Superworth

Immuneering shares outstanding IMRX

Diluted shares outstanding, averaged over each quarter, from 2020.

Latest quarter, to Jun 30, 2026
64.7M
On a year earlier
+79.8%
more shares

Immuneering had 64.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.

That is 79.8% more than a year earlier, so each share owns a little less of the company.

Shares outstanding over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearShares, fourth quarterChange
FY202564.6M+108%
FY202431.1M+6%
FY202329.3M+11%
FY202226.4M+2%
FY202126M+425%
FY20205Mn/a

Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.

Quarter by quarter

QuarterEndedShares outstandingOn a year earlier
Q2 FY2664.7M+80%
Q1 FY2664.7M+82%
Q4 FY2564.6M+108%
Q3 FY2539.7M+33%
Q2 FY2536M+21%
Q1 FY2535.5M+21%
Q4 FY2431.1M+6%
Q3 FY2429.8M+2%
Q2 FY2429.7M+4%
Q1 FY2429.4M+11%
Q4 FY2329.3M+11%
Q3 FY2329.3M+11%

What the shares outstanding tells you

Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.

A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.

More on Immuneering

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.